Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GS.8ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
GS.8ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
GS.8ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
GS.8ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
GS.8ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
GS.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GS.8ORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-20516.2China
GS.8ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-20306.2China
GS.8ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
GS.8ORF1abYoung-ORF1abCACTTAATGTAAGGCTTTGTTAAG2433.331424314220R-22408Singapore
GS.8ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
GS.8ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
GS.8ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
GS.8ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
GS.8ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
GS.8ORF1abChan-ORF1abGTGTGATGTTGAWATGACATGGTC2441.671635316330R-13317.5China
GS.8ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
GS.8ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17655.9Hong Kong
GS.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GS.8SYoung-SATCCAGCCTCTTATTATGTTAGAC2437.52187621853R-22070.7Singapore
GS.8SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-27219.1China
GS.8SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-22073.5China
GS.8SWon-SCTACATGCACCAGCAACTGT20502311423133F-17500.9South Korea
GS.8SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
GS.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GS.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GS.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GS.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GS.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GS.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.8NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
GS.8NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
GS.8NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
GS.8NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
GS.8NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
GS.8NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
GS.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GS.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GS.8NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
GS.8NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
GS.8NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
GS.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.8NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
GS.8NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
GS.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GS.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GS.8NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
GS.8NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used